2008
DOI: 10.4103/0255-0857.42033
|View full text |Cite
|
Sign up to set email alerts
|

Incidence of carbapenem-resistant <i> Pseudomonas aeruginosa</i> in diabetes and cancer patients

Abstract: Two hundred and thirty isolates of Pseudomonas aeruginosa were obtained from samples of patients having diabetes (75%), cancer (20%), and both diabetes and cancer (5%) who were admitted to a tertiary care hospital in Western India from January to December 2006. These isolates were tested for susceptibility to antipseudomonal drugs and considered to be resistant to carbapenem when the zone of inhibition around imipenem and meropenem discs was ≤13 mm. Of these 230 isolates, 26% were found to be carbapenem resist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 7 publications
1
7
0
Order By: Relevance
“…In the current study, males were found to be more commonly affected (64%) with different infections caused by non-fermenters than females (36%) which is comparable to the findings of Varaiya et al who observed that 66.66% were males and 33.3% were females [14]. Nan-Yao Lee et al reported 67.4% were males and 32.6% were females [15].…”
Section: Discussionsupporting
confidence: 89%
“…In the current study, males were found to be more commonly affected (64%) with different infections caused by non-fermenters than females (36%) which is comparable to the findings of Varaiya et al who observed that 66.66% were males and 33.3% were females [14]. Nan-Yao Lee et al reported 67.4% were males and 32.6% were females [15].…”
Section: Discussionsupporting
confidence: 89%
“…In previous studies from other parts of the world, varying rates of resistance (4 to 70%) have been reported for imipenem and meropenem (Varaiya et al, 2008;Gonlugur et al, 2004;Sanchez-Romero et al, 2003;Gladstone et al, 2005).…”
Section: Discussionmentioning
confidence: 92%
“…2 There are both economic and scientific reasons for this slowdown in antibiotic development. 3 From the economic perspective, it is difficult for pharmaceutical companies to generate a substantial profit from antibiotics.…”
Section: Mohit Kumar Phdmentioning
confidence: 99%